7-Ketocholesterol Effects on Osteogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells

Beatriz Araújo Oliveira1, Débora Levy1, Jessica Liliane Paz1

  • 1Lipids, Oxidation, and Cell Biology Team, Laboratory of Immunology (LIM19), Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 05403-900, SP, Brazil.

Insights

7-ketocholesterol (7-KC) promotes osteogenic differentiation in human adipose-derived mesenchymal stem cells (ATMSCs) by activating Wnt/β-catenin signaling. It also inhibits adipogenic differentiation, offering potential applications in bone disease treatments and regenerative medicine.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Regenerative Medicine

Background:

  • Oxysterols influence mesenchymal stem cell (MSC) differentiation.
  • The specific role of 7-ketocholesterol (7-KC) in osteogenesis is largely unknown.
  • Investigating 7-KC's impact on human adipose-derived MSCs (ATMSCs) is crucial.

Purpose of the Study:

  • To elucidate the effect of 7-ketocholesterol (7-KC) on the osteogenic differentiation of human adipose-derived mesenchymal stem cells (ATMSCs).
  • To determine if 7-KC influences adipogenic differentiation in ATMSCs.
  • To explore the underlying signaling pathways involved in 7-KC's effects on ATMSC differentiation.

Main Methods:

  • ATMSCs were cultured in osteogenic or adipogenic media with 7-KC.
  • Osteogenic and adipogenic differentiation were assessed using Alizarin Red and Oil Red O staining.
  • Gene expression of osteogenic (ALPL, RUNX2, BGLAP) and adipogenic (PPARƔ, C/EBPα) markers was analyzed via RT-PCR.
  • Key signaling pathway components (SHh, Smo, Gli-3, β-catenin) were examined using immunofluorescence.

Main Results:

  • 7-KC treatment enhanced Alizarin Red staining in osteogenic cultures.
  • 7-KC reduced adipocyte formation in adipogenic cultures.
  • Expression of early osteogenic genes (ALPL, RUNX2) increased, while adipogenic markers (PPARƔ, C/EBPα) decreased.
  • 7-KC upregulated β-catenin expression, indicating Wnt/β-catenin pathway activation, without altering SHh, Smo, or Gli-3 levels.

Conclusions:

  • 7-ketocholesterol (7-KC) promotes osteogenic differentiation of ATMSCs, particularly during the matrix maturation phase, by activating the Wnt/β-catenin pathway.
  • 7-KC concurrently inhibits adipogenic differentiation of ATMSCs.
  • These findings suggest 7-KC's potential therapeutic utility in regenerative medicine for bone regeneration and treating bone-related disorders.